BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 17718387)

  • 21. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches.
    Pereira S; Bourgeois P; Navarro C; Esteves-Vieira V; Cau P; De Sandre-Giovannoli A; Lévy N
    Mech Ageing Dev; 2008; 129(7-8):449-59. PubMed ID: 18513784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the involvement of lamins in aging.
    Rodríguez S; Eriksson M
    Curr Aging Sci; 2010 Jul; 3(2):81-9. PubMed ID: 20044904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.
    Kane MS; Lindsay ME; Judge DP; Barrowman J; Ap Rhys C; Simonson L; Dietz HC; Michaelis S
    Am J Med Genet A; 2013 Jul; 161A(7):1599-611. PubMed ID: 23666920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.
    Han X; Feng X; Rattner JB; Smith H; Bose P; Suzuki K; Soliman MA; Scott MS; Burke BE; Riabowol K
    Nat Cell Biol; 2008 Nov; 10(11):1333-40. PubMed ID: 18836436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the mouse Lmna gene causing progeria, muscular dystrophy and cardiomyopathy.
    Kozlov S; Mounkes L; Cutler D; Sullivan T; Hernandez L; Levy N; Rottman J; Stewart CL
    Novartis Found Symp; 2005; 264():246-58; discussion 258-63. PubMed ID: 15773758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.
    Kandert S; Lüke Y; Kleinhenz T; Neumann S; Lu W; Jaeger VM; Munck M; Wehnert M; Müller CR; Zhou Z; Noegel AA; Dabauvalle MC; Karakesisoglou I
    Hum Mol Genet; 2007 Dec; 16(23):2944-59. PubMed ID: 17881656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered splicing in prelamin A-associated premature aging phenotypes.
    De Sandre-Giovannoli A; Lévy N
    Prog Mol Subcell Biol; 2006; 44():199-232. PubMed ID: 17076270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamin A-linked progerias: is farnesylation the be all and end all?
    Smallwood DT; Shackleton S
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):281-6. PubMed ID: 20074075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A-type lamins and progeroïd syndromes : persistent farnesylation with dramatic effects].
    Navarro CL; Poitelon Y; Lévy N
    Med Sci (Paris); 2008 Oct; 24(10):833-40. PubMed ID: 18950579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neonatal progeroid syndrome (Wiedemann-Rautenstrauch): a model for the study of human aging?
    Arboleda G; Ramírez N; Arboleda H
    Exp Gerontol; 2007 Oct; 42(10):939-43. PubMed ID: 17728088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Truncated prelamin A expression in HGPS-like patients: a transcriptional study.
    Barthélémy F; Navarro C; Fayek R; Da Silva N; Roll P; Sigaudy S; Oshima J; Bonne G; Papadopoulou-Legbelou K; Evangeliou AE; Spilioti M; Lemerrer M; Wevers RA; Morava E; Robaglia-Schlupp A; Lévy N; Bartoli M; De Sandre-Giovannoli A
    Eur J Hum Genet; 2015 Aug; 23(8):1051-61. PubMed ID: 25649378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
    Gonzalo S; Kreienkamp R; Askjaer P
    Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LMNA mutations in progeroid syndromes.
    Huang S; Kennedy BK; Oshima J
    Novartis Found Symp; 2005; 264():197-202; discussion 202-7, 227-30. PubMed ID: 15773755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS).
    Dreesen O
    Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell depletion in Hutchinson-Gilford progeria syndrome.
    Rosengardten Y; McKenna T; Grochová D; Eriksson M
    Aging Cell; 2011 Dec; 10(6):1011-20. PubMed ID: 21902803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hutchinson-Gilford progeria in the light of contemporary genetics].
    Madej-Pilarczyk A
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):355-62. PubMed ID: 17028399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse models of the laminopathies.
    Stewart CL; Kozlov S; Fong LG; Young SG
    Exp Cell Res; 2007 Jun; 313(10):2144-56. PubMed ID: 17493612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear protein import is reduced in cells expressing nuclear envelopathy-causing lamin A mutants.
    Busch A; Kiel T; Heupel WM; Wehnert M; Hübner S
    Exp Cell Res; 2009 Aug; 315(14):2373-85. PubMed ID: 19442658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria.
    Kirschner J; Brune T; Wehnert M; Denecke J; Wasner C; Feuer A; Marquardt T; Ketelsen UP; Wieacker P; Bönnemann CG; Korinthenberg R
    Ann Neurol; 2005 Jan; 57(1):148-51. PubMed ID: 15622532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.